반응식
[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]([F:26])([F:25])[F:24])=[C:6]([C@H:8]2[CH2:12][CH2:11][CH2:10][N:9]2[C:13]2[CH:18]=[CH:17][N:16]3[N:19]=[CH:20][C:21]([NH2:22])=[C:15]3[N:14]=2)[CH:7]=1.C1N=CN([C:32]([N:34]2[CH:38]=N[CH:36]=[CH:35]2)=[O:33])C=1.N1CC[C@H:41]([OH:44])C1>C(Cl)Cl>[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]([F:26])([F:24])[F:25])=[C:6]([C@H:8]2[CH2:12][CH2:11][CH2:10][N:9]2[C:13]2[CH:18]=[CH:17][N:16]3[N:19]=[CH:20][C:21]([NH:22][C:32]([N:34]4[CH2:35][CH2:36][C@H:41]([OH:44])[CH2:38]4)=[O:33])=[C:15]3[N:14]=2)[CH:7]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a DCM (1 mL) solution of (R)-5-(2-(5-fluoro-2-(trifluoromethyl)phenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (25 mg, 0.068 mmol) was added CDI (22 mg, 0.14 mmol) at ambient temperature in one portion. After stirring for two hours, (S)-pyrrolidin-3-ol (18 mg, 0.21 mmol) was added in one portion. The reaction was stirred overnight before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 0 to 60% acetonitrile/water to yield the final product as a yellowish solid (28 mg, 86% yield). MS (apci) m/z=479.2 (M+H).
후처리
- stirringThe reaction was stirred overnight before it
- concentrationwas concentrated
- customdirectly purified by reverse-phase column chromatography
- washeluting with 0 to 60% acetonitrile/water
출처 및 근거
- ORD 기록
- ord-8639f7df984d4fa09f5d628522951e4d
- 출처 데이터셋
- uspto-grants-2015_09
- 특허 번호
- US09127013B2
연결된 노트
불러오는 중…